Alessandra Maiken Rünger

graph of relations

Publications

  1. 2024
  2. Sentinel lymph node risk prognostication in primary cutaneous melanoma through tissue-based profiling, potentially redefining the need for sentinel lymph node biopsy

    Kött, J., Zimmermann, N., Zell, T., Rünger, A., Heidrich, I., Geidel, G., Smit, D. J., Hansen, I., Abeck, F., Schadendorf, D., Eggermont, A., Puig, S., Hauschild, A. & Gebhardt, C., 05.2024, In: EUR J CANCER. 202, 113989.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  3. High Serum Levels of CCL20 Are Associated with Recurrence and Unfavorable Overall Survival in Advanced Melanoma Patients Receiving Immunotherapy

    Kött, J., Hoehne, I., Heidrich, I., Zimmermann, N., Reese, K-L., Zell, T., Geidel, G., Rünger, A. M., Schneider, S., Pantel, K., Smit, D. J. & Gebhardt, C., 29.04.2024, In: CANCERS. 16, 9, 1737.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. 2023
  5. Neoadjuvant cemiplimab induces durable complete response in locally advanced cutaneous squamous cell carcinoma

    Geidel, G., Adam, L., Rünger, A., Menz, A., Kött, J., Haalck, T. & Gebhardt, C., 12.2023, In: J EUR ACAD DERMATOL. 37, 12, p. e1414-e1416

    Research output: SCORING: Contribution to journalLetterResearchpeer-review